By Sharon AtienoKenya risks a vaccination crisis if the country does not honour its Global Alliance for Vaccines and ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Nadofaragene firadenovec intravesical gene therapy continues to show promise in treating BCG-unresponsive NMIBC bladder cancer.

ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...

A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

With one of the largest tuberculosis (TB) outbreaks in US history, Kansas has more to worry about than its recent Super Bowl ...

With increasing mass movement, including due to climate change and war, the maxim "TB anywhere is TB everywhere" is more ...